MSO Press Release: Colonial Management Group (CMG) now offering Buprenorphine/Suboxone in all their clinics

FOR IMMEDIATE RELEASE: February 23, 2008 Contact Persons: Carol Sholiton, Founder/Director, E: [email protected]; Chuck Hilger, Colonial Management Group, E: [email protected] Colonial Management Group (CMG) Now offering Suboxone in all Clinics Colonial Management Group (CMG), with 54 opiate addiction treatment centers located throughout the United States, announced that as of January 1, 2008 all of their facilities are now offering Buprenorphine (Brand name Suboxone) in addition to their Methadone Maintenance Program. Suboxone (Buprenorphine/Naloxone) received approval by the FDA on October 8, 2002. It is state of the art medication to treat the medical condition of Opioid addiction. It is improving the quality of life for patients in recovery and giving them hope, dignity, and the ability to have a normal life again. CMG focuses the work in their clinics on managing the disease of addiction and strive to improve their patients' quality of life. This involves implementing the most current research findings in the treatment of their patients.